General
COVID lives updates: South Korea resumes use of AstraZeneca vaccine for people under 60 after blood clot concerns
South Korea resumes use of AstraZeneca vaccine
South Korea says it will resume administrating AstraZeneca’s COVID-19 vaccine to all eligible people between the ages of 30 and 60.
Last week, it suspended the use of the vaccine for people under 60 while awaiting the outcome of the European Medicine Agency’s review.
The EMA said it had found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults (you can read more on that here).
The Korea Disease Control and Prevention Agency now says it will restart the use of AstraZeneca vaccine beginning Monday, citing studies showing that the vaccine’s benefits outweighs the risk of side effects.
An agency statement said people under 30 will be…
-
Noosa News19 hours agoFarmers angry as Woolworths imports US butter in green and gold packaging
-
General16 hours agoLiberal politicians on Qantas plane that made urgent turnaround to Adelaide
-
Noosa News17 hours agoTeen to be sentenced over stabbing of grandmother Vyleen White; Victoria follows Queensland with ‘adult time for violent crime’ laws
-
Noosa News15 hours agoMenulog announces shock closure in Australia after ‘challenging circumstances’